Dernière mise à jour: Août 17, 2026
Ubislate7+ (The upgraded version of Aakash)
About Ubislate7+
The much awaited India’s ultra low cost Aakash tablet is finally here and is creating ripples all around. Datawind launched Ubislate7 in India, and the student version is named as the Aakash tablet. It offers a web delivery platform that enables quality and interactive knowledge over the internet.
The CEO of DataWind, M. Suneet Singh Tuli says ‘This is a made-in-India product. Thank you for giving me the opportunity to do this.’ He adds, ‘The final goal is to either provide the same features at a lower cost or provide better functionality and features at the same cost.’
The team of engineers at Datawind has come up with the upgraded version of the Aakash tablet. This upgraded version of Aakash is called Ubislate7+.
Ubislate7+ will be commercially available everywhere and to everyone. This next generation of Aakash is loaded with better features and specifications, and any person can buy it.
The Telecom and Education Minister, Kapil Sibbal, said at the launch of Aakash, “The rich have access to the digital world, the poor and ordinary have been excluded. Aakash will end that digital divide.”
There is definitely no other touch pad tablet or computing device anywhere near the price of Aakash tablet or Ubislate7+. It is a new generation device which comes with attractive features. This is the world’s cheapest tablet pc. This tab is made for the requirement of the users and especially for student needs.
Examen de cas scientifiques
Souhaitez-vous savoir si les programmes cliniques actuels, développements récents en recherche, ou des approches émergentes peuvent être adapté à votre situation individuelle?
Envoyez votre question à notre équipe scientifique. Le siège social de NBScience au Royaume-Uni coordonne les demandes de renseignements à travers le réseau international de centres médicaux, scientifiques, et consultants spécialisés.
- Examen des informations que vous fournissez
- Informations pertinentes sur la recherche et les programmes cliniques
- Une réponse claire et adaptée à votre situation
Aucune obligation. Votre question sera examinée de manière confidentielle.
Informations pédagogiques et de recherche uniquement. Ce service ne constituer un avis médical, diagnostic, ordonnance, ou un personnalisé recommandation de traitement.
